Definitive Contract 75F40121C00158
Award Date 9/17/21
Potential Completion Date 9/16/23
Potential Value $281K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration (FDA) has awarded a $749,661.00 firm fixed-price definitive contract to Duke University, a prestigious private research institution located in Durham, North Carolina. The contract is not set-aside and was issued under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. The BAA solicits basic and applied research and development proposals to support the FDA's mission of protecting and promoting...
- The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
- This is a definitive contract awarded by the Food and Drug Administration (FDA) to Duke University in the amount of $1,046,733.02. The contract is for the "USE OF ELECTRONIC HEALTH RECORDS AS SOURCE DATA FOR CLINICAL RESEARCH" and has an ultimate completion date of December 28, 2020. The contract has a cost-no-fee pricing type and was not set aside for any socioeconomic program. Duke University, through its Office of Research Administration Division, is the prime contractor on this...
- The Department of Health and Human Services Food and Drug Administration awarded a definitive cost-no-fee contract to Duke University Office of Research Administration Division for the "Evaluating Fitness-for-Use of Electronic Health Records in Clinical Research" project. The contract has a potential value of $1,269,675.26 and a completion date of December 30, 2022. This contract is not set aside. As the prime contractor, Duke University will provide clinical research and...
- This is a $699,087 firm-fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Duke University, a prestigious private research institution located in Durham, North Carolina. The contract is for basic and applied research and development to support regulatory science and innovation, in alignment with the FDA's mission to protect and promote public health. This award is part of the FDA's agency-wide Broad Agency Announcement (BAA) for research and development. The...
- The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $21,659,151.36 definitive cost-no-fee contract to Duke University to support the "ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES." This contract, which does not have a set-aside designation, will run through September 18, 2026. Duke University's Office of Research Administration Division will serve as the prime contractor on this...
- This is a delivery order awarded to Duke University under the Vaccine and Treatment Evaluation Units (VTEU) program, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The $7,573,172.56 award is for consultation and testing of cytokine levels and cell activation in clinical samples. Duke University, a private research university, is the prime contractor for this cost-no-fee contract with a performance period ending on December 31, 2023....
- This is a $1,206,589.24 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is for research and development to quantify patient priorities for clinical evidence on the impact of osseointegrated limb prostheses. This award was made under the FDA's Broad Agency Announcement for regulatory science and innovation research, with no set-aside designation. Duke University has previously received...
- This is a definitive contract awarded by the Department of the Navy Naval Sea Systems Command to Duke University's Office of Research Administration Division, a private non-profit university, on January 25, 2019. The contract is for a research study with a potential value of $299,112.00 and a completion date of October 30, 2021. The contract is a cost-no-fee type, and there was no set-aside designation indicated. Duke University has a history of providing a variety of goods and services to the...